Php33 - Understanding the Japanese Policy Initiatives and the Patient Characteristics of Rare, Intractable Diseases

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Understanding the Pathophysiology and Searching for Biomarkers for Rare Genetic Developmental Diseases

Proceedings
2019English

Characteristics and Enlightenment of Japanese Policy Evaluation Method

Open Journal of Legal Science
2015English

Policy Initiatives for Health and the Bioeconomy

OECD Science, Technology and Industry Policy Papers
2019English

The Japanese Smart Grid Initiatives, Investments, and Collaborations

International Journal of Advanced Computer Science and Applications
Computer Science
2012English

Erratum to : Research Committees and Their Reports on Intractable Diseases Specified by the Japanese Ministry of Health and Welfare

Igaku Toshokan
1985English

Approval of the Patient Care Line With Rare Diseases, Brazil’s Portaria 199 and Its National Policy. What Does That Mean? What Changes?

Revista de Medicina da UFC
2017English

Treatment and Care of Intractable Neurological Diseases

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2011English

Understanding the Japanese Mind.

Archives of Internal Medicine
1954English

Characteristics of Patients Contacting a Center for Undiagnosed and Rare Diseases

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy